Marinomed Biotech AG (MARI.VI)

4.50EUR +0.00% (+0.00)

Over 6M: -75.4%

2026-08-25
5 10 15
Mar Apr May Jun Jul Aug

Figures as at 2023-12-31, reported in EUR. The newest fact in the filings is dated 2024-01-01, 968 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
Oper. margin -55.9%
ROIC -191.6%
OE margin -49.3%

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.74×

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -18.6%

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.

The ratios

The figures themselves rather than their scores — what somebody looking up MARI.VI on one particular measure came for.

RatioValue
cash operating margin-55.85
current ratio0.74
current ratio reported0.74
fcf margin-49.31
interest cover-2.03
operating margin-55.85
owner earnings margin-49.31
revenue growth-18.56
revenue growth per share-18.56
roic-191.59
rule of 40-74.41
sbc pct revenue0.0

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 2,588,800 CashAndCashEquivalents 2024-01-01
current assets 7,135,400 CurrentAssets 2024-01-01
current liabilities 9,653,200 CurrentLiabilities 2024-01-01
equity -10,136,400 Equity 2024-01-01
interest expense 2,523,400 FinanceCosts 2023-12-31
ocf -4,528,200 CashFlowsFromUsedInOperatingActivities 2023-12-31
revenue 9,183,500 Revenue 2023-12-31

What to be careful about

See it scored yourself

The dashboard puts MARI.VI beside other companies and lets you change what counts: the weight of each dimension, the value that earns a ten, and which of the 61 measures are included at all.